(VIANEWS) – SPBK1 ØSTFOLD AKE (SOAG.OL), KBC (KBC.BR), TOTENS SPAREBANK (TOTG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SPBK1 ØSTFOLD AKE (SOAG.OL)
27.3% sales growth and 10.79% return on equity
SpareBank 1 Østfold Akershus, a savings bank, provides various banking products and services in Østfold and the southern part of Akershus. The company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. It also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; liquidity loans with government guarantees; operating credit for agriculture; mortgage products; leasing and factoring services; and refinancing services. In addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, truck, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. Further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; accounting approved, invoice automatic, eGiro/Cremul, KID invoice, and OCR and eGiro payment services; and mobile and online banking services. The company was founded in 1835 and is headquartered in Moss, Norway.
Earnings Per Share
As for profitability, SPBK1 ØSTFOLD AKE has a trailing twelve months EPS of kr35.73.
PE Ratio
SPBK1 ØSTFOLD AKE has a trailing twelve months price to earnings ratio of 8.9. Meaning, the purchaser of the share is investing kr8.9 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.79%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 34.6%, now sitting on 980M for the twelve trailing months.
Yearly Top and Bottom Value
SPBK1 ØSTFOLD AKE’s stock is valued at kr318.00 at 02:20 EST, way under its 52-week high of kr368.00 and way above its 52-week low of kr280.00.
Volume
Today’s last reported volume for SPBK1 ØSTFOLD AKE is 61 which is 90.71% below its average volume of 657.
More news about SPBK1 ØSTFOLD AKE.
2. KBC (KBC.BR)
27.2% sales growth and 13.72% return on equity
KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services. It also provides digital and mobile banking services. The company was formerly known as KBC Bank and Insurance Holding Company NV and changed its name to KBC Group NV in March 2005. KBC Group NV was incorporated in 1935 and is headquartered in Brussels, Belgium.
Earnings Per Share
As for profitability, KBC has a trailing twelve months EPS of €7.49.
PE Ratio
KBC has a trailing twelve months price to earnings ratio of 8.15. Meaning, the purchaser of the share is investing €8.15 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.72%.
Yearly Top and Bottom Value
KBC’s stock is valued at €61.04 at 02:20 EST, way under its 52-week high of €72.46 and way higher than its 52-week low of €45.53.
Volume
Today’s last reported volume for KBC is 45162 which is 93.9% below its average volume of 740751.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 6 and the estimated forward annual dividend yield is 9.81%.
Moving Average
KBC’s worth is under its 50-day moving average of €62.46 and above its 200-day moving average of €58.77.
More news about KBC.
3. TOTENS SPAREBANK (TOTG.OL)
22.5% sales growth and 10.47% return on equity
Totens Sparebank provides various banking and financial products and services in Norway. The company offers savings and pension products; business and construction loans; leasing; overdrafts and bank guarantees; liability, business, data attack, property damage, craftsman, health, homeowners, collective, personnel, travel, occupational injury, agriculture, and vehicle insurance; and business and credit cards. It also provides online and mobile banking services; payment solutions; asset management; and real estate services. Totens Sparebank was founded in 1854 and is headquartered in Lena, Norway.
Earnings Per Share
As for profitability, TOTENS SPAREBANK has a trailing twelve months EPS of kr20.54.
PE Ratio
TOTENS SPAREBANK has a trailing twelve months price to earnings ratio of 9.64. Meaning, the purchaser of the share is investing kr9.64 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.47%.
Moving Average
TOTENS SPAREBANK’s worth is below its 50-day moving average of kr218.04 and below its 200-day moving average of kr204.65.
Volume
Today’s last reported volume for TOTENS SPAREBANK is 93 which is 81.62% below its average volume of 506.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 51.7% and 14.9%, respectively.
More news about TOTENS SPAREBANK.
4. MOWI (MOWI.OL)
19.9% sales growth and 24.25% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr19.62.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 9.8. Meaning, the purchaser of the share is investing kr9.8 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.25%.
More news about MOWI.
5. MELEXIS (MELE.BR)
10.3% sales growth and 41.13% return on equity
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN transceiver, CAN transceiver, RFID Transceiver NFC Sensor tag ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Earnings Per Share
As for profitability, MELEXIS has a trailing twelve months EPS of €4.94.
PE Ratio
MELEXIS has a trailing twelve months price to earnings ratio of 17.35. Meaning, the purchaser of the share is investing €17.35 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.13%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 4.2% and 8.3%, respectively.
Sales Growth
MELEXIS’s sales growth is 16.8% for the current quarter and 10.3% for the next.
More news about MELEXIS.
6. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.69.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 22.43. Meaning, the purchaser of the share is investing kr22.43 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
More news about NAVAMEDIC.
7. IMCD (IMCD.AS)
6.5% sales growth and 19.97% return on equity
IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers bioactives, biocides, chelates, functional additives, rheology modifiers, silicones, solubilisers, and solvents; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, surfactants, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents. It also provides taste, texture, nutrition, and function; base oil, fuel addictive, lubricants addictive, lubricants finished fluids, solvents, degreasers and fuel, compounds, and upstream, midstream and downstream oil, gas and energy; bio-based chemicals, binders, corrosion inhibitors, catalysts, intermediates, monomers, organic building blocks, processing aids, reactive diluents, solvents, and surfactants. IMCD N.V. was founded in 1995 and is headquartered in Rotterdam, the Netherlands.
Earnings Per Share
As for profitability, IMCD has a trailing twelve months EPS of €5.49.
PE Ratio
IMCD has a trailing twelve months price to earnings ratio of 25.79. Meaning, the purchaser of the share is investing €25.79 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
More news about IMCD.
